If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
15.50
Ask:
15.55
Spread: 0.05 (0.323%)
Market Cap: £124.23m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Board Appointment

31 Oct 2012 07:00

RNS Number : 8589P
Allocate Software PLC
31 October 2012
 



 

31 October 2012

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Board Appointment

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, has appointed Lynn Drummond (53) as a Non-Executive Director. She will join the board with effect from 1 November 2012.

 

Dr. Drummond has a strong track record within the life sciences sector, bringing over twenty years of management and advisory experience. Lynn spent 16 years at Rothschild in London most recently as a Managing Director within the investment banking division, with a particular focus on transactions within the healthcare sector. Prior to this she worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. Lynn is also a non-executive director of Consort Medical plc and Alimentary Health Ireland.

 

Dr. Drummond holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is also a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

 

Commenting on the appointment, Terry Osborne, Chairman of Allocate Software plc said: "I am delighted to welcome Lynn to the Board of Directors of Allocate Software. Lynn is a high calibre individual with significant success and experience of governance in highly regarded healthcare organisations, government and the financial markets. Her appointment will further strengthen our Board as Allocate becomes a more significant and influential player in its markets."

 

Lynn Drummond commented: "I am very pleased to be joining the Board of Allocate Software. The Company has enjoyed rapid growth and great success in recent years, notably in the healthcare sector and I am looking forward to working with the team to help them achieve their ambitious plans in the next phase of growth."

 

Details of Dr Drummond's current and previous directorships and partnerships in the past five years are set out below.

 

Current directorships and partnerships:

Consort Medical plc

Alimentary Health, Ireland

Previous directorships and partnerships:

Breast Cancer Haven

 

She does not currently hold any ordinary shares in Allocate Software plc.

There is no further information in connection with the appointment of Dr Drummond to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Simon Willis /

Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.Allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFSFIRLIVIF
Date   Source Headline
20th Nov 20247:00 amRNS-RInvestor Presentation - Swiss Mining Institute
5th Nov 20247:00 amRNSTR-1 Notification of Major Holdings
30th Oct 20247:00 amRNSNotice of AGM
25th Oct 20247:00 amRNSSuccessful Completion of A$10m Equity Placing
24th Oct 20244:35 pmRNSA$9 million Equity Placing
24th Oct 20244:31 pmRNSQuarterly Activities and Cash Flow Report
8th Oct 20247:00 amRNSGrant of Mine Operating Permit
18th Sep 20247:00 amRNS2024 Annual Financial Report
12th Sep 20247:00 amRNSGrant of Ewoyaa Lithium Mining Project EPA Permit
16th Aug 20247:00 amRNSGrant of Performance Rights to Employees
30th Jul 20247:15 amRNSQuarterly Activities and Cash Flow Report
30th Jul 20247:00 amRNSNew Dog-Leg Target Delivers Increase to Ewoyaa MRE
12th Jul 20248:30 amRNSEwoyaa Lithium Project Update
10th Jul 20247:00 amRNSFatal Incident at the Ewoyaa Lithium Project
30th May 20247:00 amRNSField Work Underway at Senya Beraku Licence
15th May 20249:55 amRNSBoard Appointment - Replacement
15th May 20247:00 amRNSBoard Appointment
10th May 20247:00 amRNSAdmission to Trading on the Ghana Stock Exchange
7th May 20247:10 amRNSConference Attendance – CG Global Metals & Mining
7th May 20247:00 amRNSDog-Leg Delivers Further High-grade Intersections
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.